Phosphodiesterase inhibitors prevent NSAID enteropathy independently of effects on TNF-α release

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 277, Issue 4 40-4, 1999, Pages

  Reuter, Brian K ^a   Wallace, John L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cyclooxygenase; Enteritis; Inflammation; Nonsteroidal anti inflammatory drugs; Tumor necrosis factor ; Ulcer

Indexed keywords

BILE ACID; DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM; THALIDOMIDE; THEOPHYLLINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CYTOKINE RELEASE; DRUG MECHANISM; ENTEROPATHY; HISTOPATHOLOGY; INTESTINE INJURY; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

EID: 0032699064     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1999.277.4.g847     Document Type: Article

References (39)

1. Anthony, A., A. K. Bahl, I. G. Oakley, C. F. Spraggs, A. P. Dhillon, M. A. Trevethick, C. K. Piasecki, R. E. Pounder, and A. J. Wakefield. The β-adrenoceptor agonist CL316243 prevents indomethacin-induced jejunal ulceration in the rat by reversing early villous shortening. J. Pathol. 179: 340-346, 1996.
2. Appleyard, C. B., D. M. McCafferty, A. W. Tigley, M. G. Swain, and J. L. Wallace. Tumor necrosis factor mediation of NSAID-induced gastric damage: role of leukocyte adherence. Am. J. Physiol. 270 (Gastrointest. Liver Physiol. 33): G42-G48, 1996.
3. Bertrand, V., R. Guimbaud, P. Sogni, A. Lamrani, C. Mauprivez, J. P. Giroud, D. Couturier, L. Chauvelot-Moachon, and S. Chaussade. Role of tumour necrosis factor-α and inducible nitric oxide synthase in the prevention of nitro-flurbiprofen small intestine toxicity. Eur. J. Pharmacol. 356: 245-253, 1998.
4. Bertrand, V., R. Guimbaud, M. Tulliez, C. Mauprivez, P. Sogni, D. Couturier, J. P. Giroud, S. Chaussade, and L. Chauvelot-Moachon. Increase in tumor necrosis factor-α production linked to the toxicity of indomethacin for the rat small intestine. Br. J. Pharmacol. 124: 1385-1394, 1998.
5. Bjarnason, I., J. Hayllar, A. J. MacPherson, and A. S. Russell. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 104: 1832-1847, 1993.
6. Brodie, D. A., P. G. Cook, B. J. Bauer, and G. E. Dagle. Indomethacin-induced intestinal lesions in the rat. Toxicol. Appl. Pharmacol. 17: 615-624, 1970.
7. Chensue, S. W., D. G. Remick, C. Shmyr-Forsch, T. F. Beals, and S. L. Kunkel. Immunohistochemical demonstration of cytoplasmic and membrane-associated tumor necrosis factor in murine macrophages. Am. J. Pathol. 133: 564-572, 1988.
8. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
9. Cooper, A. L., S. Brouwer, A. V. Turnball, G. N. Luheshi, S. J. Hopkins, S. L. Kunkel, and N. J. Rothwell. Tumor necrosis factor-α and fever after peripheral inflammation in the rat. Am. J. Physiol. 267 (Regulatory Integrative Comp. Physiol. 36): R1431-R1436, 1994.
10. Davies, N. M., A. G. Roseth, C. B. Appleyard, W. McKnight, P. del Soldato, A. Calignano, G. Cirino, and J. L. Wallace. NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects. Aliment. Pharmacol. Ther. 11: 69-79, 1997.
11. Ferraz, J.-G. P., A. W. Tigley, C. B. Appleyard, and J. L. Wallace. TNF-α contributes to the pathogenesis of ethanol-induced gastric damage in cirrhotic rats. Am. J. Physiol. 272 (Gastrointest. Liver Physiol. 35): G809-G814, 1997.
12. Flynn, W. J., H. G. Cryer, and R. N. Garrison. Pentoxifylline restores intestinal microvascular blood flow during resuscitated hemorrhagic shock. Surgery 110: 350-356, 1991.
13. Guimbaud, R., V. Bertrand, L. Chauvelot-Moachon, G. Quartier, N. Vidon, J. P. Giroud, D. Couturier, and S. Chaussade. Network of inflammatory cytokines and correlation with disease activity in ulcerative colitis. Am. J. Gastroenterol. 93: 2397-2404, 1998.
14. Hamilton, L. J., Y. Dai, and G. D. F. Jackson. Bile regulates the expression of major histocompatibility complex class II molecules on rat intestinal epithelium. Gastroenterology 113: 1901-1905, 1997.
15. Jackson, G. D. F., Y. Dai, C. Fung, and P. G. C. Hansen. Tumour necrosis factor-α - a constitutive protein of bile. In: Advances in Mucosal Immunology, edited by J. Mestecky, C. Blair, and P. L. Ogra. New York: Plenum, 1995, p. 1083-1086.
16. 3-adrenoceptor agonist. Aliment. Pharmacol. Ther. 12: 1121-1129, 1998.
17. Kent, T. H., R. M. Cardelli, and F. W. Stamler. Small intestinal ulcers and intestinal flora in rats given indomethacin. Am. J. Pathol. 54: 237-249, 1969.
18. Kirisits, M. J., D. Vardimon, H. W. Kunz, and T. J. Gill III. Mapping of the TNFA locus in the rat. Immunogenetics 39: 59-60, 1994.
19. Langman, M. J. S., L. Morgan, and A. Worrall. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br. Med. J. 290: 347-349, 1985.
20. Lifrak, E. T., R. A. Erickson, L. Halbur, and E. Quimbo. Role of tumor necrosis factor-α (TNF-α) in NSAID-induced intestinal ulceration (Abstract). Gastroenterology 108: A149, 1995.
21. Melarange, R., C. Gentry, M. Durie, C. O'Connell, and P. R. Blower. Gastrointestinal irritancy, anti-inflammatory activity, and prostanoid inhibition in the rat: differentiation of effects between nabumetone and etodolac. Dig. Dis. Sci. 39: 601-608, 1994.
22. Melarange, R., G. Moore, P. R. Blower, M. E. Coates, F. W. Ward, and V. Ronaasen. A comparison of indomethacin with ibuprofen on gastrointestinal mucosal integrity in conventional and germ-free rats. Aliment. Pharmacol. Ther. 6: 67-77, 1992.
23. Miura, S., M. Suematsu, S. Tanaka, H. Nagata, S. Houzawa, M. Suzuki, I. Kurose, H. Serizawa, and M. Tsuchiya. Microcirculatory disturbance in indomethacin-induced intestinal ulcer. Am. J. Physiol. 261 (Gastrointest. Liver Physiol. 24): G213-G219, 1991.
24. Morris, A. J., R. Madhok, R. D. Sturrock, H. A. Capell, and J. F. MacKenzie. Enteropscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet 337: 520, 1991.
25. Morris, A. J., L. A. Wasson, and J. F. MacKenzie. Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut 33: 887-889, 1992.
26. Reuter, B. K., N. M. Davies, and J. L. Wallace. Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation. Gastroenterology 112: 109-117, 1997.
27. Ribbons, K. A., J. H. Thompson, X. P. Liu, K. Pennline, D. A. Clark, and M. J. S. Miller. Anti-inflammatory properties of interleukin-10 administration in hapten-induced colitis. Eur. J. Pharmacol. 323: 245-254, 1997.
28. Robert, A., and T. Asano. Resistance of germ-free rats to indomethacin-induced intestinal lesions. Prostaglandins 14: 333-341, 1977.
29. Salcedo, C., J. Puig, J. M. Palacios, and A. G. Fernandez. Phosphodiesterase 4 inhibition, a new mechanism to maintain and promote gastric and intestinal integrity against NSAID-induced injury in the rat (Abstract). Gastroenterology 114: A274, 1998.
30. Samlaska, C. P., and E. A. Winfleld. Pentoxifylline. J. Am. Acad. Dermatol. 30: 603-621, 1994.
31. Sampaio, E. P., E. N. Sarno, R. Galilly, Z. A. Cohn, and G. Kaplan. Thalidomide selectively inhibits tumour necrosis factor production by stimulated human monocytes. J. Exp. Med. 173: 699-703, 1991.
32. Santucci, L., S. Fiorucci, M. Giansanti, P. M. Brunori, F. M. Di Matteo, and A. Morelli. Pentoxifylline prevents indomethacin-induced acute gastric mucosal damage in rats: role of tumor necrosis factor-α. Gut 35: 909-915, 1994.
33. Steeb, G. D., M. A. Wilson, and R. N. Garrison. Pentoxifylline preserves small-intestine microvascular blood flow during bacteremia. Surgery 112: 756-763, 1992.
34. Thompson, W. J. Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function. Pharmacol. Ther. 51: 13-33, 1991.
35. 2 and 3′,5′-cyclic adenosine monophosphate levels and of indomethacin-induced ulceration in the rat. Life Sci. 48: 2035-2042, 1991.
36. Wallace, J. L., B. Reuter, C. Cicala, and G. W. McKnight. A diclofenac derivative without ulcerogenic properties. Eur. J. Pharmacol. 257: 249-255, 1994.
37. Wax, J., W. A. Clinger, P. Varner, P. Bass, and C. V. Winder. Relationship of the enterohepatic cycle to ulcerogenesis in the rat small bowel with flufenamic acid. Gastroenterology 58: 772-780, 1970.
38. Wong, H., W. D. Anderson, T. Cheng, and K. T. Riabowol. Monitoring mRNA expression by polymerase chain reation: the "primer-dropping" method. Anal. Biochem. 223: 251-258, 1994.
39. Yamada, T., E. Deitch, R. D. Specian, M. A. Perry, R. B. Sartor, and M. B. Grisham. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 17: 641-662, 1993.